John M. Robertson
Experienced in Endometrial Stromal Sarcoma

Dr. John M. Robertson

Radiation Oncology
Corewell Health
Rose Cancer Treatment Center
3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
On Staff At
Accepting New Patients
41 Years of Experience
Experienced in Endometrial Stromal Sarcoma
Corewell Health
Rose Cancer Treatment Center
3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Robertson is a Radiation Oncologist in Royal Oak, Michigan. Dr. Robertson has been practicing medicine for over 41 years and is rated as an Experienced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Anal Cancer, Bone Tumor, Liposarcoma, and Chordoma. Dr. Robertson is currently accepting new patients.

His clinical research consists of co-authoring 23 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Michigan Medical School, 1985
Residency
Beaumont Hospital
Specialties
Radiation Oncology
Licenses
Radiology in MI
Board Certifications
American Board Of Radiology
Fellowships
University of Michigan Hospitals and Health Centers
Hospital Affiliations
Corewell Health Trenton Hospital
Corewell Health Dearborn Hospital
Corewell Health Wayne Hospital
Corewell Health Beaumont Troy Hospital
Corewell Health William Beaumont University Hospital
Corewell Health Taylor Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Rose Cancer Treatment Center
3577 West 13 Mile Road, Suite Ll, Royal Oak, MI 48073
Call: 248-551-5490

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2025
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2025
Intervention Type: Other
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Enrollment Status: Completed
Publish Date: October 20, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

23 Total Publications

Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377.
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377.
Journal: International journal of radiation oncology, biology, physics
Published: September 25, 2024
View All 23 Publications
Similar Doctors
Maha S. Jawad
Distinguished in Endometrial Stromal Sarcoma
Dr. Maha S. Jawad
Radiation Oncology
Distinguished in Endometrial Stromal Sarcoma
Dr. Maha S. Jawad
Radiation Oncology

Rose Cancer Treatment Center

3577 West 13 Mile Road, Suite Ll, 
Royal Oak, MI 
 (0.1 miles away)
248-551-5490
Experience:
16+ years
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Maha Jawad is a Radiation Oncologist in Royal Oak, Michigan. Dr. Jawad has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Breast Cancer, and Vaginal Cancer. Dr. Jawad is currently accepting new patients.

Advanced in Endometrial Stromal Sarcoma
Dr. Eva B. Bieniek
Radiation Oncology
Advanced in Endometrial Stromal Sarcoma
Dr. Eva B. Bieniek
Radiation Oncology

Huron River Radiation Oncology Specialists PC

775 S Main St, 
Chelsea, MI 
 (44.4 miles away)
734-593-5690
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eva Bieniek is a Radiation Oncologist in Chelsea, Michigan. Dr. Bieniek is rated as an Advanced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer. Dr. Bieniek is currently accepting new patients.

Krisha Howell
Advanced in Endometrial Stromal Sarcoma
Dr. Krisha Howell
Radiation Oncology
Advanced in Endometrial Stromal Sarcoma
Dr. Krisha Howell
Radiation Oncology

MHP Radiation Oncology Institute

4550 Investment Drive, Suite B111, 
Troy, MI 
 (5.1 miles away)
248-952-5019
Experience:
20+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Krisha Howell is a Radiation Oncologist in Troy, Michigan. Dr. Howell has been practicing medicine for over 20 years and is rated as an Advanced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Liposarcoma, Endometrial Cancer, Adult Soft Tissue Sarcoma, Pancreaticoduodenectomy, and Splenectomy. Dr. Howell is currently accepting new patients.

VIEW MORE ENDOMETRIAL STROMAL SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Robertson's expertise for a condition
ConditionClose
    • Distinguished
    • Anal Cancer
      Dr. Robertson is
      Distinguished
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Advanced
    • Bone Tumor
      Dr. Robertson is
      Advanced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Robertson is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Adenoid Cystic Carcinoma
      Dr. Robertson is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adrenal Cancer
      Dr. Robertson is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Adrenocortical Carcinoma
      Dr. Robertson is
      Experienced
      . Learn about Adrenocortical Carcinoma.
      See more Adrenocortical Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Robertson is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Robertson is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.